Literature DB >> 7774900

Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer.

J Berumen1, E R Unger, L Casas, P Figueroa.   

Abstract

The distribution and amplification patterns of human papillomavirus were studied in 15 human papillomavirus (HPV) 16- and six HPV18-positive cervical carcinomas by colorimetric in situ hybridization (ISH). The findings were correlated with the viral copy number and status of E1/E2 viral genes in the tumor DNA, as studied by dot blot analysis and the polymerase chain reaction, respectively. The tumors were classified according to the ISH signal into single dot, multidot, diffuse, and mixed patterns. The signal was homogeneously distributed only in single dot tumors and was clearly heterogeneous in tumors with mixed nuclear signal patterns, including both dot and diffuse signals. The single dot pattern predominated in HPV 18-positive tumors (83%), whereas the multidot pattern was most frequent in HPV 16-positive tumors (47%). Diffuse and mixed patterns were noted only in HPV 16-positive tumors (33%). The lowest mean copy of number per cell was observed in single dot tumors (25 +/- 15) with an ascendent trend toward the diffuse signal tumors (2832 +/- 2281). E1/E2 genes were disrupted in 75% of the single/multidot tumors and in none of the diffuse/mixed tumors. These data suggest diffuse signals originate by episomal amplification and dot signals originate by viral integration. Diffuse and dot patterns suggest different mechanisms of viral transformation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7774900     DOI: 10.1016/0046-8177(95)90175-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

1.  Human papilloma virus detection by in situ hybridisation signal amplification based on biotinylated tyramine deposition.

Authors:  K Cooper; L Taylor
Journal:  Mol Pathol       Date:  1997-08

2.  Novel binding sites for regulatory factors in the human papillomavirus type 18 enhancer and promoter identified by in vivo footprinting.

Authors:  P H Bednarek; B J Lee; S Gandhi; E Lee; B Phillips
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

Review 3.  Human papillomavirus, integration and cervical carcinogenesis: a clinicopathological perspective.

Authors:  K Cooper; J O McGee
Journal:  Mol Pathol       Date:  1997-02

4.  Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer.

Authors:  Hugo Arias-Pulido; Cheri L Peyton; Nancy E Joste; Hernan Vargas; Cosette M Wheeler
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

5.  Prognostic significance of high-risk human papillomavirus and p16(INK4A) in patients with esophageal squamous cell carcinoma.

Authors:  Fangli Cao; Weihong Zhang; Fang Zhang; Hui Han; Junlong Xu; Yufeng Cheng
Journal:  Int J Clin Exp Med       Date:  2014-10-15

Review 6.  Molecular events in uterine cervical cancer.

Authors:  S A Southern; C S Herrington
Journal:  Sex Transm Infect       Date:  1998-04       Impact factor: 3.519

7.  The etiologic role of human papillomavirus in penile cancers: a study in Vietnam.

Authors:  H T T Do; C Koriyama; N A Khan; M Higashi; T Kato; N T Le; S Matsushita; T Kanekura; S Akiba
Journal:  Br J Cancer       Date:  2013-01-08       Impact factor: 7.640

8.  Human papillomavirus infections in women seeking cervical Papanicolaou cytology of Durango, Mexico: prevalence and genotypes.

Authors:  Luis Francisco Sánchez-Anguiano; Cosme Alvarado-Esquivel; Miguel Arturo Reyes-Romero; Margarita Carrera-Rodríguez
Journal:  BMC Infect Dis       Date:  2006-02-20       Impact factor: 3.090

9.  Prevalence of high-risk human papillomavirus types in Mexican women with cervical intraepithelial neoplasia and invasive carcinoma.

Authors:  Rubén López-Revilla; Luz A Martínez-Contreras; Mireya Sánchez-Garza
Journal:  Infect Agent Cancer       Date:  2008-02-28       Impact factor: 2.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.